These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 8311159)
1. [The pathogenetic basis for using antiestrogens in treating patients with hyperplastic processes of the endometrium in the postmenopause]. Vysotskiĭ MM; Krasnova IA; Kostyleva OI; Eremin VL Akush Ginekol (Mosk); 1993; (6):46-9. PubMed ID: 8311159 [TBL] [Abstract][Full Text] [Related]
3. [The estrogen receptors of the endometrial plasma membranes in proliferative processes in the postmenopause]. Savel'eva GM; Sergeev PV; Breusenko VG; Mineeva EN; Kappusheva LM Akush Ginekol (Mosk); 1989 Dec; (12):60-3. PubMed ID: 2629527 [TBL] [Abstract][Full Text] [Related]
4. Effects of hormone therapy on the endometrium. Deligdisch L Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860 [TBL] [Abstract][Full Text] [Related]
5. [Immunohistochemical study of the expression of receptors to steroid hormones in endometrial hyperplastic processes]. Lysenko ON; Ashkhab MKh; Strizhova NV; Babichenko II Arkh Patol; 2004; 66(2):7-10. PubMed ID: 15154374 [TBL] [Abstract][Full Text] [Related]
7. Relative binding activity of new antigestagens with progesterone receptors in human hyperplastic endometrium. Kamernitskii AV; Levina IS; Kareva EN; Kirpichnikova NV; Mgdesyan KK; Ovchinnikova EV Bull Exp Biol Med; 2002 Nov; 134(5):445-7. PubMed ID: 12802447 [TBL] [Abstract][Full Text] [Related]
8. Antioxidant status and sex hormones in women with complex endometrial hyperplasia. Pejić S; Todorović A; Stojiljković V; Pavlović I; Gavrilović L; Popović N; Pajović SB Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):51-56. PubMed ID: 27755952 [TBL] [Abstract][Full Text] [Related]
9. [Serum E2 and progesterone levels in patients with atypical hyperplasia and endometrial carcinoma]. Gorchev G; Maleeva A Akush Ginekol (Sofiia); 1993; 32(2):23-4. PubMed ID: 8010393 [TBL] [Abstract][Full Text] [Related]
10. Progesterone binding by human endometrial tissue during the proliferative and secretory phases of the menstrual cycle and by hyperplastic and carcinomatous endometrium. Rodriquez J; Sen KK; Seski JC; Menon M; Johnson TR; Menon KM Am J Obstet Gynecol; 1979 Mar; 133(6):660-5. PubMed ID: 426021 [TBL] [Abstract][Full Text] [Related]
11. Progestin effects on epidermal growth factor receptor (EGFR) endometrial expression in normal and hyperplastic endometrium. Jasonni VM; La Marca A; Santini D Int J Gynaecol Obstet; 2005 Jun; 89(3):297-8. PubMed ID: 15919406 [No Abstract] [Full Text] [Related]
12. [The realization of the antiestrogen effect of tamoxifen in endometrial adenomatosis in women of reproductive age]. Putyrskaia NP; Chernukha GE Akush Ginekol (Mosk); 1993; (6):43-6. PubMed ID: 8311158 [TBL] [Abstract][Full Text] [Related]
13. Quantification of Leydig cells and stromal hyperplasia in the postmenopausal ovary of women with endometrial carcinoma. Reijnen C; Küsters-Vandevelde HVN; Abbink K; Zusterzeel PLM; van Herwaarden AE; van der Laak JAWM; Massuger LFAG; Snijders MPLM; Pijnenborg JMA; Bulten J Hum Pathol; 2019 Mar; 85():119-127. PubMed ID: 30428390 [TBL] [Abstract][Full Text] [Related]
14. Female sex steroid receptors in normal, hyperplastic and carcinomatous endometrium. The relationship to serum steroid hormones and gonadotropins and changes during medroxyprogesterone acetate administration. Jänne O; Kauppila A; Kontula K; Syrjälä P; Vihko R Int J Cancer; 1979 Nov; 24(5):545-54. PubMed ID: 231013 [No Abstract] [Full Text] [Related]
15. [The effect of E2 and progesterone on the receptor status in endometrial carcinoma]. Gorchev G; Milkov V; Tanchev S; Popov I Akush Ginekol (Sofiia); 1992; 31(2):27-8. PubMed ID: 1342552 [TBL] [Abstract][Full Text] [Related]
16. [Local hyperestradiolemia of the uterus in the pathogenesis of hyperplastic endometrial processes]. Savitskiĭ GA Vopr Onkol; 1991; 37(2):179-84. PubMed ID: 2014696 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of endometrial proliferation in pipelle biopsies in tamoxifen-treated postmenopausal women with breast cancer in Kuwait. Al-Azemi M; Labib NS; Motawy MM; Temmim L; Moussa MA; Omu AE Med Princ Pract; 2004; 13(1):30-4. PubMed ID: 14657616 [TBL] [Abstract][Full Text] [Related]
18. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia. Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295 [TBL] [Abstract][Full Text] [Related]
19. Estrogen and progesterone receptors in the endometrium of postmenopausal breast cancer patients treated with tamoxifen and progestogens. Cohen I; Altaras MM; Beyth Y; Shapira J; Figer A; Tepper R; Cordoba M; Yigal D; Bernheim J Gynecol Oncol; 1997 Apr; 65(1):83-8. PubMed ID: 9103396 [TBL] [Abstract][Full Text] [Related]
20. Molecular markers in the endometrium at baseline of postmenopausal patients with early breast cancer in the ATAC (Arimidex, tamoxifen, alone, or in combination) trial. Duffy SR; Taylor L Am J Obstet Gynecol; 2004 Dec; 191(6):1921-7. PubMed ID: 15592273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]